Patents by Inventor Thomas Schrader

Thomas Schrader has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260138987
    Abstract: Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: January 16, 2026
    Publication date: May 21, 2026
    Inventors: Jill Melissa BACCEI, Yalda BRAVO, Austin Chih-Yu CHEN, Jeffrey ROPPE, Thomas SCHRADER, Yifeng XIONG
  • Patent number: 12565501
    Abstract: Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: March 3, 2026
    Assignee: Contineum Therapeutics, Inc.
    Inventors: Jill Melissa Baccei, Yalda Bravo, Austin Chih-Yu Chen, Jeffrey Roppe, Thomas Schrader, Yifeng Xiong
  • Patent number: 12482959
    Abstract: An electrical contact element having a frame clamp comprises a frame with a stationary thread, a clamping shoe and a clamping screw engaging in the stationary thread and being supported on the clamping shoe. A plastic holder with a cavity having two insertion openings arranged on opposite walls of the cavity is provided for inserting two electrical conductors to be contacted with one another, in which the frame clamp is arranged. The frame clamp is captively fixed in the cavity of the plastic holder by means of a latching. The frame clamp is mounted in a floating manner in the cavity of the plastic holder in the direction of at least one axis, which is oriented orthogonally to an insertion direction of the electrical contacts into the insertion openings.
    Type: Grant
    Filed: February 16, 2023
    Date of Patent: November 25, 2025
    Assignee: BRUSS SEALING SYSTEMS GMBH
    Inventors: Samuel Neumann, Thomas Schrader, Patrick Danberg, Manfred Brand
  • Patent number: 12390462
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Grant
    Filed: July 25, 2023
    Date of Patent: August 19, 2025
    Assignee: Contineum Therapeutics, Inc.
    Inventors: Yifeng Xiong, Jeffrey Roppe, Austin Chih-Yu Chen, Yalda Bravo, Thomas Schrader, Jill Melissa Baccei
  • Patent number: 12368340
    Abstract: The invention relates to an electrical conductor for conducting electric current through a housing part, wherein the electrical conductor is enclosed on a first sealing section by a sealing body made of an elastic material, wherein the electrical conductor and the sealing body have an integrally-bonded connection. The electrical conductor has, at least in the first sealing section, an outer contour which is rounded in cross-section. The invention further relates to a method for producing an electrical conductor with a sealing body, which is connected by integral bonding and is made of an elastic material.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: July 22, 2025
    Assignee: BRUSS SEALING SYSTEMS GMBH
    Inventors: Manfred Brand, Jürgen Grundt, Ralf Pielke, Timo Besoke, Samuel Neumann, Thomas Schrader, Patrick Danberg
  • Publication number: 20250179045
    Abstract: Described herein, inter alia, are LPAR1 antagonists and uses thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: June 5, 2025
    Inventors: Jeffrey Roger Roppe, Austin Chih-Yu Chen, Yifeng Xiong, Thomas Schrader
  • Publication number: 20250171455
    Abstract: Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds, pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 29, 2025
    Inventors: Jill Melissa BACCEI, Yalda BRAVO, Austin Chih-Yu CHEN, Jeffrey ROPPE, Thomas SCHRADER, Yifeng XIONG
  • Publication number: 20250034110
    Abstract: Described herein, inter alia, are LPAR1 antagonists and uses thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: January 30, 2025
    Inventors: Jeffrey Roger Roppe, Austin Chih-Yu Chen, Yifeng Xiong, Thomas Schrader, Lino Valdez
  • Publication number: 20250026758
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: June 18, 2024
    Publication date: January 23, 2025
    Inventors: Thomas Schrader, Yifeng Xiong, Jill Baccei, Jeffrey Roppe, Austin Chen
  • Patent number: 12054487
    Abstract: Provided, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: August 6, 2024
    Assignee: Contineum Therapeutics, Inc.
    Inventors: Thomas Schrader, Yifeng Xiong, Jill Baccei, Jeffrey Roppe, Austin Chen
  • Publication number: 20240217981
    Abstract: Disclosed herein, inter alia, are a crystalline compound of mAChR M1 antagonist, its pharmaceutical composition and methods of treatment.
    Type: Application
    Filed: April 13, 2022
    Publication date: July 4, 2024
    Inventors: Jeffrey Roppe, Jill Melissa Baccei, Austin Chih-Yu Chen, Yifeng Xiong, Thomas Schrader, Yalda Bravo
  • Publication number: 20230364082
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: July 25, 2023
    Publication date: November 16, 2023
    Inventors: Yifeng Xiong, Jeffrey Roppe, Austin Chih-Yu Chen, Yalda Bravo, Thomas Schrader, Jill Melissa Baccei
  • Patent number: 11752149
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: September 12, 2023
    Assignee: Pipeline Therapeutics, Inc.
    Inventors: Yifeng Xiong, Jeffrey Roppe, Austin Chih-Yu Chen, Yalda Bravo, Thomas Schrader, Jill Melissa Baccei
  • Publication number: 20230275366
    Abstract: An electrical contact element having a frame clamp comprises a frame with a stationary thread, a clamping shoe and a clamping screw engaging in the stationary thread and being supported on the clamping shoe. A plastic holder with a cavity having two insertion openings arranged on opposite walls of the cavity is provided for inserting two electrical conductors to be contacted with one another, in which the frame clamp is arranged. The frame clamp is captively fixed in the cavity of the plastic holder by means of a latching. The frame clamp is mounted in a floating manner in the cavity of the plastic holder in the direction of at least one axis, which is oriented orthogonally to an insertion direction of the electrical contacts into the insertion openings.
    Type: Application
    Filed: February 16, 2023
    Publication date: August 31, 2023
    Inventors: SAMUEL NEUMANN, THOMAS SCHRADER, PATRICK DANBERG, MANFRED BRAND
  • Publication number: 20230089921
    Abstract: Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: October 6, 2020
    Publication date: March 23, 2023
    Inventors: Jill Melissa Baccei, Yalda Bravo, Austin Chih-Yu Chen, Jeffrey Roppe, Thomas Schrader, Yifeng Xiong
  • Publication number: 20230024874
    Abstract: The invention relates to an electrical conductor for conducting electric current through a housing part, wherein the electrical conductor is enclosed on a first sealing section by a sealing body made of an elastic material, wherein the electrical conductor and the sealing body have an integrally-bonded connection. The electrical conductor has, at least in the first sealing section, an outer contour which is rounded in cross-section. The invention further relates to a method for producing an electrical conductor with a sealing body, which is connected by integral bonding and is made of an elastic material.
    Type: Application
    Filed: July 19, 2022
    Publication date: January 26, 2023
    Inventors: MANFRED BRAND, JÜRGEN GRUNDT, RALF PIELKE, TIMO BESOKE, SAMUEL NEUMANN, THOMAS SCHRADER, PATRICK DANBERG
  • Patent number: 11512090
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: November 29, 2022
    Assignee: Pipeline Therapeutics, Inc.
    Inventors: Yifeng Xiong, Thomas Schrader, Austin Chen, Jeffrey Roger Roppe, Jill Melissa Baccei, Yalda Bravo
  • Publication number: 20220332721
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: June 10, 2019
    Publication date: October 20, 2022
    Inventors: Yifeng XIONG, Thomas SCHRADER, Austin CHEN, Jeffrey Roger ROPPE, Jill Melissa BACCEI, Yalda BRAVO
  • Publication number: 20210161889
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: November 24, 2020
    Publication date: June 3, 2021
    Inventors: Yifeng Xiong, Jeffrey Roppe, Austin Chih-Yu Chen, Yalda Bravo, Thomas Schrader, Jill Melissa Baccei
  • Publication number: 20210155629
    Abstract: Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
    Type: Application
    Filed: September 3, 2019
    Publication date: May 27, 2021
    Inventors: Thomas Schrader, Yifeng Xiong, Jill Baccei, Jeffrey Roppe, Austin Chen